First Affiliated Hospital of Shandong First Medical University, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, 250117, China.
NHC Key Laboratory of Biotechnology Drugs (Shandong Academy of Medical Sciences), Ji'nan, 250117, Shandong, China.
Int Microbiol. 2024 Feb;27(1):277-290. doi: 10.1007/s10123-023-00384-8. Epub 2023 Jun 15.
Polymyxin B is considered a last-line therapeutic option against multidrug-resistant gram-negative bacteria, especially in COVID-19 coinfections or other serious infections. However, the risk of antimicrobial resistance and its spread to the environment should be brought to the forefront.
Pandoraea pnomenusa M202 was isolated under selection with 8 mg/L polymyxin B from hospital sewage and then was sequenced by the PacBio RS II and Illumina HiSeq 4000 platforms. Mating experiments were performed to evaluate the transfer of the major facilitator superfamily (MFS) transporter in genomic islands (GIs) to Escherichia coli 25DN. The recombinant E. coli strain Mrc-3 harboring MFS transporter encoding gene FKQ53_RS21695 was also constructed. The influence of efflux pump inhibitors (EPIs) on MICs was determined. The mechanism of polymyxin B excretion mediated by FKQ53_RS21695 was investigated by Discovery Studio 2.0 based on homology modeling.
The MIC of polymyxin B for the multidrug-resistant bacterial strain P. pnomenusa M202, isolated from hospital sewage, was 96 mg/L. GI-M202a, harboring an MFS transporter-encoding gene and conjugative transfer protein-encoding genes of the type IV secretion system, was identified in P. pnomenusa M202. The mating experiment between M202 and E. coli 25DN reflected the transferability of polymyxin B resistance via GI-M202a. EPI and heterogeneous expression assays also suggested that the MFS transporter gene FKQ53_RS21695 in GI-M202a was responsible for polymyxin B resistance. Molecular docking revealed that the polymyxin B fatty acyl group inserts into the hydrophobic region of the transmembrane core with Pi-alkyl and unfavorable bump interactions, and then polymyxin B rotates around Tyr43 to externally display the peptide group during the efflux process, accompanied by an inward-to-outward conformational change in the MFS transporter. Additionally, verapamil and CCCP exhibited significant inhibition via competition for binding sites.
These findings demonstrated that GI-M202a along with the MFS transporter FKQ53_RS21695 in P. pnomenusa M202 could mediate the transmission of polymyxin B resistance.
多黏菌素 B 被认为是对抗多重耐药革兰氏阴性菌的最后一线治疗选择,尤其是在 COVID-19 合并感染或其他严重感染中。然而,应该将抗生素耐药性的风险及其向环境中的传播提上日程。
从医院污水中选择 8mg/L 多黏菌素 B 对 Pandoraea pnomenusa M202 进行分离培养,然后通过 PacBio RS II 和 Illumina HiSeq 4000 平台进行测序。进行交配实验以评估基因组岛 (GI) 中主要易化因子超家族 (MFS) 转运蛋白向大肠杆菌 25DN 的转移。还构建了携带 MFS 转运蛋白编码基因 FKQ53_RS21695 的重组大肠杆菌菌株 Mrc-3。确定了流出泵抑制剂 (EPI) 对 MIC 的影响。基于同源建模,使用 Discovery Studio 2.0 研究了 FKQ53_RS21695 介导的多黏菌素 B 排泄机制。
从医院污水中分离出的多药耐药菌 Pandoraea pnomenusa M202 对多黏菌素 B 的 MIC 为 96mg/L。在 Pandoraea pnomenusa M202 中鉴定出了携带 MFS 转运蛋白编码基因和 IV 型分泌系统接合转移蛋白编码基因的 GI-M202a。M202 和大肠杆菌 25DN 之间的交配实验反映了通过 GI-M202a 转移多黏菌素 B 耐药性的可能性。EPI 和异源表达实验也表明,GI-M202a 中的 MFS 转运蛋白基因 FKQ53_RS21695 负责多黏菌素 B 耐药性。分子对接表明,多黏菌素 B 的脂肪酰基插入跨膜核心的疏水区,与 Pi-烷基和不利的凸起相互作用,然后多黏菌素 B 围绕 Tyr43 旋转,在排出过程中使肽段向外显示,同时 MFS 转运蛋白发生从内向外的构象变化。此外,维拉帕米和 CCCP 通过竞争结合位点表现出显著的抑制作用。
这些发现表明,Pandoraea pnomenusa M202 中的 GI-M202a 及其 MFS 转运蛋白 FKQ53_RS21695 可以介导多黏菌素 B 耐药性的传播。